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Intracysticpapillarycarcinomaisararemalignanttumorofthebreast.Itoccurscommunallyinpostmenopausalwomen.Clinically
itcanbeasymptomaticormanifestedbyabreastmassoranippledischarge.Onimagingintracysticpapillarycarcinomahasusually
benign features. Pathologic diagnosis can be diﬃcult at classical histological examination and identiﬁcation of myoepithelial cells
layer by immunohistochemical study can be useful. In the majority of cases of pure intracystic papillary carcinoma, conservative
management is possible. Adjuvant therapy is still controversial and prognosis is excellent. We report three cases of intracystic
papillary carcinoma diagnosed on immunohistochemical examination and managed with conservative surgery.
1.Introduction
Intracystic papillary carcinoma is an uncommon breast dis-
ease, constituting 0.5% to 1% of all breast cancers [1]. Pap-
illary carcinomas are classiﬁed histologically into intraductal
and intracystic papillary carcinoma [2]. Intracystic papillary
carcinomas (IPCs) are further divided into pure form or
associated to a ductal carcinoma in situ (DCIS) or invasive
carcinoma [1].
ClinicalandradiologicmanifestationsofIPCarenotspe-
c i ﬁ c .O nu l t r a s o n o g r a p h y ,i tc a nb eap u r ec y s t ,am i x e di m -
age, or a solid mass.
The recent use of immunohistochemical identiﬁcation of
myoepithelial cellslayer(MEC)of the cystsseemsto enhance
pathologic diagnosis performance but its inﬂuence on prog-
nosis is to be determined.
Therapeutic management of IPC is also still controver-
sial. Endocrine therapy and radiation are used by many cen-
ters but evidence of their role in prognosis improvement is
still lacking.
2.CaseReport 1
A 58-year-old woman presented with a mass in the upper
internal quadrant of the left breast, without pain or nipple
discharge.
Physical examination revealed a 2cm mass, non-well-
deﬁned, ﬁxed and ﬁrm, nonpainful, and without skin chan-
ges.
Mammography showed an oval opacity of the upper
internal quadrant with no calciﬁcations (Figure 1). Ultra-
sonography showed a cystic mass measuring 27mm, with
posterior acoustic enhancement and a little solid component
(Figure 2). Surgical excision was performed.
At the pathologic examination, the tumor was a cyst con-
taining a solid grey material.
Histological examination revealed an intracystic papil-
loma with atypical hyperplasia. Immunohistochemical study
did not found neither anti-p63 nor anti-cytokeratin 5/6 anti-
bodies and conclude to an intracystic papillary carcinoma.
Surgical margins were negative.2 Case Reports in Obstetrics and Gynecology
Figure 1: Mediolateral oblique mammogram which shows a soft-
tissue mass, well limited in the left breast.
Figure 2: Ultrasonography showed a cystic mass of 27mm, with
posterior acoustic enhancement, and a solid component.
The patient received an adjuvant treatment based on
endocrine therapy and breast radiation. There was no recur-
rence at 13 months of follow-up.
3.CaseReport 2
A 40-year-old patient, with a history of surgery for an intra-
ductal papilloma of the left breast three years ago, presented
with a mass of the same breast.
Physical examination revealed a 3cm, well-circum-
scribed mass, ﬁrm and painless, in the lower internal quad-
rant of the left breast. There were no axillary nodes.
On sonography the mass was heterogeneous with solid
and cystic components, measuring 25mm (Figure 3). These
ﬁnding suggested a benign tumor and surgical excision was
performed.
Mammography shows a homogeneous lobulated opacity
of the lower and internal quadrant of the left breast without
calciﬁcations.
Figure 3:Heterogeneousmasswithtissularandcysticcomponents.
Figure 4: Papillae with mild cellular atypia.
Histological examination revealed an intracystic papil-
lary carcinoma with positive surgical margins. Immunohis-
tochemicalstudyshowsabsenceofMEClayerandconﬁrmed
the diagnosis.
A conservative surgical reexcision was performed, and
surgical margins were free of disease. No adjuvant radiation
or endocrine therapy was administered.
At the follow-up of 9 months, there was no recurrence.
4.CaseReport 3
A 70-year-old patient presented with a breast lump. Exami-
nation found a painless, well-circumscribed mass measuring
4cm, without axillary nodes.
Mammographyhasshownaroundregularopacity, with-
out calciﬁcations. Sonography revealed a pure cystic mass.
Surgical excision was performed with frozen section ex-
amination. It revealed an intracystic papilloma with atypia
(Figure 4). The deﬁnitive pathological examination con-
ﬁrmed this ﬁnding. Immunohistochemical study showed a
complete negativity of P63 compatible with the diagnosis of
intracysticpapillarycarcinoma.Surgicalmarginswerefreeof
disease and the patient has not received adjuvant treatment.
The patient presented a recurrence one year after the ﬁrst
surgery and was managed by a second conservative surgery.Case Reports in Obstetrics and Gynecology 3
5. Discussion
Papillary carcinoma of the breast is a rare malignant tumor,
constituting1-2%ofallbreastcarcinomasinwomen[3].Itis
distinguishedbythepapillarystructuraldesign:proliferation
characterized by ﬁnger-like projections or fronds composed
of central ﬁbrovascular cores covered by epithelium, without
myoepithelial cell layer (which diﬀerentiate between benign
and malignant papillary lesion). It can be divided into in-
vasive and noninvasive forms. Noninvasive papillary carci-
nomas are further subdivided into two subtypes: a diﬀuse
form, the papillary variant of ductal carcinoma in situ, and
a localized form, intracystic papillary carcinoma [1, 4]. This
localizedform,IPC,describesasolitarytumorinanencysted
or dilated duct.
The intracystic papillary carcinoma is more frequently
found among postmenopausal women with an average age
between 55 and 67 years old [5], many cases were also
described in the male population in the literature, and it is
the second men’s breast cancer [6–8].
Clinically, it frequently presents as a benign-like mass.
The tumor can also manifest with a bloody nipple discharge,
and in some cases, it can be asymptomatic and revealed by
systematic mammography. Axillaries nodes are infrequent
[4, 6].
At the mammography, the intracystic papillary carci-
noma appears as a round, ovular, or lobulated opacity. The
margins of the mass are usually circumscribed but may
be obscured or indistinct by places testifying inﬂammation
or invasion [4, 6]. There are no speculations. The differ-
ential diagnosis on mammographic appearance includes a
hematoma, invasive ductal carcinoma, and colloid or medul-
lar carcinoma, benign cyst, or adenoﬁbroma [9].
On ultrasonography, the lesion might have an indistinct
border or microlobulation, which might suggest that it is
malignancy, it is often complex in echo texture and shows
both cystic (anechogenic) and solid (echogenic) compo-
nents, the cystic portion may contain septation, with solid
papillary mass projecting into the cystic lumen, internal
echoes may be identiﬁed, and they often related to sponta-
neous hemorrhage within the tumor in the cyst [2, 10, 11].
Color Doppler is helpful to demonstrate the intramural
blood ﬂow within the solid component of the mass.
An important size of the intracystic vegetation, the
heterogeneous echo texture, and irregular border of the solid
papillary mass are criteria for malignancy suspicion.
The magnetic resonance imaging (MRI) is sensitive but
not speciﬁc in detecting papillary tumors. It is useful in
case of multiple papillomatosis, but without any interest to
distinguish benign and malignant lesions [2, 8].
The combination of a residual palpable mass and a
frankly bloody aspirate at the ﬁne needle aspiration is a
strongest indicator of carcinoma.
Core needle biopsy of the intracystic mass with ultra-
sonographic guidance has been used by many authors for
distinguishing benign from malignant papillary lesions, but
it has a low accuracy for distinguishing between in situ or
invasive papillary carcinoma because the site of biopsy is
generally central while the invasion is usually found in the
periphery of the tumor [4, 6].
Surgical excision is recommended after core-needle
biopsy if there is atypia, high-risk lesion, positivity for malig-
nancy, or imaging-histological discordance. Biopsy excision
is often performed directly when papillary carcinoma is
suggested by sonography or mammography.
We performed surgical excision for all our patients be-
cause of patient’s age and the presence of a solid component.
We think that, in these cases, the sensitivity of core needle
biopsy is low and it does not allow skipping the surgical
excision anyway.
For Tomonori et al. [12], also, excisional biopsy is neces-
sary because IPC is more diﬃcult to diagnose than common
breast cancer preoperatively; ﬁne needle aspiration and core
needle biopsy are not suﬃc i e n tm o s to ft h et i m e .
Indeed, the surgical excision allows the pathologist to
classify the papillary lesion by classical histological exami-
nation and especially with immunohistochemical study and
to research invasion or DCIS in surroundings breast tissues,
present in majority of cases [13].
Identiﬁcation of a myoepithelial cell layers essentially
by immunohistochemical analysis has become a key feature
in distinguishing benign from malignant and in situ from
invasive papillary lesions of the breast [14, 15]. In the case
of IPC, there is completely a lack of myoepithelial cell layers
both in the proliferating intraluminal component of the
lesion and in the basal layer at the periphery, a situation
similar to invasive papillary carcinoma, but with ﬁbrous
capsule surrounding it, so many authors recently describe
IPC as an encapsulated low-grade invasive carcinoma and
accept it as a borderline lesion in progression from in situ
to invasive carcinoma [7, 13, 16].
Thelargestseriesofintracysticpapillarycarcinomainthe
literature, with an analysis of over 900 cases of IPC, retro-
spectively from the data of the California Cancer Registry
(CCR), reviewed from the years 1988 to 2005, demonstrate
that distinguishing between in situ or invasive IPC is likely
not of clinical signiﬁcance because, regardless of the classiﬁ-
cation, the prognosis is excellent [7].
There are no evidence-based guidelines for treatment
of IPC. There is no randomized controlled trial comparing
breast conserving surgery to mastectomy. However, many
case reports and retrospective studies showed excellent prog-
nosis with conservative surgery without axillary dissection
in IPC not associated to DCIS or microinvasion lesions
[1, 17, 18].
Sentinel node biopsy may be an excellent alternative to
full axillary dissection in patients with IPC and associated
invasive carcinoma [1].
There is also lack of evidence about the role of adjuvant
therapy.Inoneofthebiggestseries[18]wefoundintheliter-
ature, Fayanju et al. reviewed the management of 45 patients
with IPC in order to determine factors associated with the
use of adjuvant therapy. In this study, authors concluded that
the most important factor determining the use of radiation
and endocrine therapies is associated pathology (DCIS or
microinvasion) and patients with pure IPC were less likely
to undergo radiation and endocrine therapies.4 Case Reports in Obstetrics and Gynecology
Even if IPC is associated to breast DCIS or invasion,
its prognosis is still excellent when treatment decisions are
tailored to associated pathology [18].
Inthiscontextoflackofevidenceaboutadjuvanttherapy,
we based the use of adjuvant therapy on the patient’s opinion
after informing them that these treatments are optional.
6. Conclusion
Intracystic papillary carcinoma is rare breast malignancy,
with an excellent prognosis in its pure form.
Suspected at sonography in front of cyst with internal
solid component, occurred to premenopausal woman, it will
be conﬁrmed by histopathology and immunohistochemical
study after surgical excision.
The mainstay of treatment is surgical resection, with
adjuvanttherapyifassociatedtoDCISorinvasivecarcinoma.
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